22nd Century Group: Disrupting The Plant-Based Markets With Improved Genetics
22nd Century Group: Disrupting The Plant-Based Markets With Improved Genetics 22nd Century Group, Inc. (NYSE:XXII) is a plant biotechnology company covering the tobacco, hemp and cannabis markets. “At our core, think of us as the Intel Inside of cannabis. We’re a disruptive plant-based biotechnology company,” said CEO Jim Mish, presenting at the virtual Benzinga Cannabis Capital Conference on Thursday. 22nd Century was founded on a mission to bring forward a product able to reduce the harm caused by nicotine-based cigarettes, and later expanded to other plant lines including marijuana,...